Original ResearchPublished 29 September 2026NMA plus antitumor therapy versus antitumor therapy alone in patients with BCLC stage B or C hepatocellular carcinoma and pre-cachexia or cachexia: protocol for a prospective, multicenter, randomized, open-label phase II trialRuihong Dai · Facheng Lu · Weibing Leng · Qing He · Wenhao Guo · Tao Hai · Chang LiuFrontiers in Gastroenterologydoi 10.3389/fgstr.2026.1926294
